Sunday, November 5, 2017
- 9:00AM-11:00AM
-
Abstract Number: 403
Cardiac Immune Cells in SKG Mice with Inflammatory Arthritis before and after Myocardial Infarction
Rheumatoid Arthritis – Animal Models Poster I- 9:00AM-11:00AM
-
Abstract Number: 741
Cardiac MRI in Systemic Sclerosis As Prognostic Tool of Cardiac Mortality in Symptomatic Patients
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster I- 9:00AM-11:00AM
-
Abstract Number: 735
Cardiopulmonary Exercise Testing to “Detect” Pulmonary Arterial Hypertension in Systemic Sclerosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster I- 9:00AM-11:00AM
-
Abstract Number: 803
Cardiovascular Risk Factors and Comorbid Diseases in Takayasu’s Arteritis
Vasculitis Poster I: Large Vessel Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 527
Cardiovascular Safety of Tocilizumab Versus Abatacept in Patients with Rheumatoid Arthritis: A Multi-Database Study
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster I: Comorbidities and Adverse Events; Efficacy and Safety of Small Molecules- 9:00AM-11:00AM
-
Abstract Number: 58
Cartilage-like Tissue Generation By 3D-Bioprinting of Induced Pluripotent Stem Cells
Biology and Pathology of Bone and Joint Poster I- 9:00AM-11:00AM
-
Abstract Number: 331
Case Series: Comparison of Repository Corticotropin Injection (H.P. Acthar Gel) Versus Glucocorticoids on Bone Density in SLE Patients
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 145
Cause-Specific Mortality in a Large Population-Based Cohort of Rheumatoid Arthritis Patients in Italy
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 673
Cell Bound Complement Activation Products Distinguish Systemic Lupus Erythematosus from Other Diseases Among Patients with High Antinuclear Antibody Titers and Normal Complement
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 463
Certolizumab Pegol for Fatigue in Chronic Inflammatory Rheumatic Diseases: A Meta-Analysis
Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response- 9:00AM-11:00AM
-
Abstract Number: 189
Challenges and Opportunities of Implementing a Patient-Reported Measure of Physical Function through an Online Electronic Health Record Patient Portal in Routine Rheumatology Practice
Health Services Research Poster I- 9:00AM-11:00AM
-
Abstract Number: 330
Change in Bone Mineral Density in Patients with Rheumatoid Arthritis: Minimal 10-Year Follow-up
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 795
Characteristics and Treatment Outcomes of Giant Cell Arteritis with Large-Vessel Lesions in a Nationwide, Retrospective Cohort Study in Japan
Vasculitis Poster I: Large Vessel Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 709
Characteristics of Cardiac Diseases in Systemic Lupus Erythematosus and Risk Factors of Different Echocardiographic Features